概述
“If we threatened to take this power away from our chemists, there would be a mutiny.”That’s how discovery leaders at PTC Therapeutics view the informatics platform now in place for their team — a set of tools that lets every chemist query, analyze, and visualize all enterprise data, independently of IT and even programmers.
But what did this platform replace? Why did the original technical footprint fail to deliver? And what were the consequences for team productivity and the pace of discovery?
Join our webinar on October 22 to hear Christie Morrill, PhD, share her firsthand account of PTC’s transformation. As Research Fellow in Chemistry, Christie and her team were all too familiar with the price of siloed data, fragmented workflows, and overdependence on IT and programming on the DMTA cycle. Christie will illustrate how the introduction of Certara D360 put power back in the hands of scientists, who could now build their queries in a no-code environment, retrieve all the data they needed, and share their analyses with peers through a full range of visualizations.
She’ll then present a D360 use case: comparing the potency of a chemical series against two targets at varying concentrations. You’ll see how a process that could have involved a morass of R, SAS, and Excel spreadsheets instead proceeded through an elegant workflow on D360.
Discovery hath no fury like a chemist scorned. Learn how to avoid your own MedChem mutiny and register today.
点击报名
Research Fellow in Chemistry at PTC Therapeutics,
Christie has led medicinal chemistry scale-up, discovery, and informatics at PTC since 2008. She earned her PhD in Chemistry from the California Institute of Technology under Nobel Laureate Robert H. Grubbs, focusing on the application of transition metal catalysis to synthetic organic chemistry. Christie began her industry career at Johnson & Johnson before joining PTC, where she played a key role in implementing advanced informatics solutions to support medicinal chemists and accelerate drug discovery efforts.
点击报名
